Organization
Xiaojun Chen
5 clinical trials
Clinical trial
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients With Conservative TreatmentStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole in Obese Progestin-insensitive Early-stage Endometrial Cancer Patients With Conservative TreatmentStatus: Recruiting, Estimated PCD: 2025-03-30
Clinical trial
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma: Two Single-arm, Prospective and Open-label Clinical StudyStatus: Recruiting, Estimated PCD: 2024-02-28
Clinical trial
Weight Management Plus Levonorgestrel Intrauterine System or Megestrol Acetate in Endometrial Atypical Hyperplasia: Multiple Single-arm, Prospective and Open-label Clinical StudyStatus: Recruiting, Estimated PCD: 2024-02-28
Clinical trial
Medroxyprogesterone Acetate (MPA) Versus Dydrogesterone for Management of Endometrial Hyperplasia Without AtypiaStatus: Completed, Estimated PCD: 2022-05-14